Abstract
The pharmacological activity of 2NTX-99 ([4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide]) was investigated in vitro in the intact, rat pulmonary vasculature and in guinea pig airways. Rat lungs were perfused at constant flow and changes in vascular tone recorded. Challenge with the TXA₂ analogue 9,11-dideoxy-9α11α-methanoepoxy ProstaglandinF₂ (U46619, 0.5 μM) increased vessel tone (32.48±1.5 vs 13.13±0.56 mmHg; n=12). 2NTX-99 (0.1-100 μM; n=5), caused a concentration-dependent relaxation, prevented by 1H-[1,2,4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ, 10 μM, n=4), an inhibitor of soluble guanylate cyclase. Acetylcholine (0.1-10 μM; n=3) and a reference NO-donor, isosorbide-5-mononitrate (5-100 μM; n=4), were ineffective. Intraluminal perfusion of washed human platelets (2 × 10⁸ cells/ml) increased intravascular pressure after challenge with arachidonic acid (AA, 2 μM; n=5), an increase abolished by acetylsalicylic acid and significantly reduced by 2NTX-99 (40 μM; n=5). TXB₂ in the lung perfusate was detected after platelet activation, 2NTX-99 inhibited TXA₂ synthesis (6.45±0.6 and 1.10±0.2 ng/ml, respectively). 2NTX-99 did not alter central or peripheral airway responsiveness to Hista...Continue Reading
References
Jul 9, 1992·The New England Journal of Medicine·B W ChristmanJ E Loyd
May 1, 1991·Agents and Actions·E MasiniJ R Vane
Sep 1, 1987·British Journal of Pharmacology·M W RadomskiS Moncada
Nov 1, 1987·British Journal of Pharmacology·M W RadomskiS Moncada
Feb 1, 1996·Chest·H AizawaN Hara
Oct 1, 1995·Journal of Lipid Mediators and Cell Signalling·P V HalushkaK L Davis-Bruno
Dec 10, 1998·British Journal of Pharmacology·M G BelvisiJ A Mitchell
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·C NapoliL J Ignarro
Oct 19, 2002·Biochimica Et Biophysica Acta·Michael J CoffeyMarc Peters-Golden
Aug 19, 2003·European Journal of Pharmacology·Valérie CapraG Enrico Rovati
Jan 13, 2004·Journal of Applied Physiology·B D NossamanP J Kadowitz
Jul 19, 2005·The Journal of Pharmacology and Experimental Therapeutics·Anna-Karin LarssonSven-Erik Dahlén
Mar 14, 2007·British Journal of Pharmacology·A-K LarssonG C Folco
Oct 30, 2007·British Journal of Pharmacology·E SelgS-E Dahlén